Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Journal of Medicinal Chemistry
|
February 19, 2026
Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer Therapy
Ubaldina Galli, Marianna Moro, Federica Carolina Balestrero, et al.
Journal of Medicinal Chemistry
|
April 7, 2009
Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases
Ambra A Grolla, Valeria Podestà, Maria Giovanna Chini, et al.
Scientific Reports
|
January 9, 2021
A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability
Magdalena Nikolaeva-Koleva, Laura Butron, Sara González-Rodríguez, et al.
European Journal of Medicinal Chemistry
|
September 12, 2024
The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators
Angela Lamberti, Marta Serafini, Silvio Aprile, et al.
Cell Calcium
|
May 31, 2022
STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca<sup>2+</sup>-entry modulators CIC-37 and CIC-39
Beatrice Riva, Emanuela Pessolano, Edoardo Quaglia, et al.
Chemmedchem
|
February 6, 2007
Estrogenic analogues synthesized by click chemistry
Tracey Pirali, Silvia Gatti, Roberto Di Brisco, et al.
Journal of Medicinal Chemistry
|
May 4, 2018
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders
Marta Serafini, Alessia Griglio, Silvio Aprile, et al.
Disease Models & Mechanisms
|
November 1, 2019
A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy
Celia Cordero-Sanchez, Beatrice Riva, Simone Reano, et al.
ACS Pharmacology & Translational Science
|
October 18, 2024
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1
Eleonora Panfili, Sarah Jane Rezzi, Annalisa Adamo, et al.
Journal of Medicinal Chemistry
|
March 10, 2020
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to <i>in Vivo</i> Pharmacodynamic Activity
Marta Serafini, Enza Torre, Silvio Aprile, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Journal of Medicinal Chemistry
|
February 19, 2026
Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer Therapy
Ubaldina Galli, Marianna Moro, Federica Carolina Balestrero, et al.
Journal of Medicinal Chemistry
|
April 7, 2009
Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases
Ambra A Grolla, Valeria Podestà, Maria Giovanna Chini, et al.
Scientific Reports
|
January 9, 2021
A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability
Magdalena Nikolaeva-Koleva, Laura Butron, Sara González-Rodríguez, et al.
European Journal of Medicinal Chemistry
|
September 12, 2024
The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators
Angela Lamberti, Marta Serafini, Silvio Aprile, et al.
Cell Calcium
|
May 31, 2022
STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca<sup>2+</sup>-entry modulators CIC-37 and CIC-39
Beatrice Riva, Emanuela Pessolano, Edoardo Quaglia, et al.
Chemmedchem
|
February 6, 2007
Estrogenic analogues synthesized by click chemistry
Tracey Pirali, Silvia Gatti, Roberto Di Brisco, et al.
Journal of Medicinal Chemistry
|
May 4, 2018
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders
Marta Serafini, Alessia Griglio, Silvio Aprile, et al.
Disease Models & Mechanisms
|
November 1, 2019
A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy
Celia Cordero-Sanchez, Beatrice Riva, Simone Reano, et al.
ACS Pharmacology & Translational Science
|
October 18, 2024
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1
Eleonora Panfili, Sarah Jane Rezzi, Annalisa Adamo, et al.
Journal of Medicinal Chemistry
|
March 10, 2020
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to <i>in Vivo</i> Pharmacodynamic Activity
Marta Serafini, Enza Torre, Silvio Aprile, et al.
Page
of 7